Medications and medical expenditures for diabetic patients with osteoporosis in Beijing, China: A retrospective study
Authors' conclusion
Osteoporosis might contribute to a worse condition in diabetic patients, and this population often requires more medications with higher medical costs.
Study context
- Population
- Diabetic patients in the Beijing medical insurance database, 2016–2018
- Participants
- 2,853,036 patients
- Exposure
- Diabetic patients with vs without osteoporosis
- With osteoporosisn = 406,221
- Outcome
- Treatment regimens and medical costs
Methodological detailsinsurance database
- Insurance database
Main finding
As reported in the abstract
- Diabetes and osteoporosis most prevalent at age 45–84 years
- With osteoporosis: more prone to comorbidities and diabetic complications vs without
- With osteoporosis: often multiple glucose-lowering drugs and higher rate of insulin use
- Osteoporosis: more non-hypoglycemia medications and higher healthcare costs
- Medications and costs increased with number of complications and comorbidities
- 2016–2018: diabetic patients with osteoporosis took more drugs, but medical costs lower year by year
Observational data: associations, not effects.
Original publication
Medications and medical expenditures for diabetic patients with osteoporosis in Beijing, China: A retrospective study. Diabetes Res Clin Pract. Published 25 October 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →